October 30th 2025, 3:00pm
The FDA granted fast track designation to JSKN003 in platinum-resistant recurrent epithelial ovarian cancer, primary peritoneal cancer or fallopian tube cancer.
October 30th 2025, 1:00pm
Scalp cooling helped Maureen Green feel more like herself during chemotherapy, giving her control over her appearance at a time filled with fear and uncertainty.
October 29th 2025, 9:00pm
My first oncologist got me started with positivity in my cancer journey, which I was, thankfully able to internalize.
October 29th 2025, 8:03pm
During Liver Cancer Awareness Month, Dr. Anjana Pillai says more treatment options, growing trials and ongoing research offer hope for patients.
October 29th 2025, 7:00pm
For Stephanie Wachtel, receiving a diagnosis of triple-positive breast cancer at the age of 23 was life-changing in a number of ways.
October 29th 2025, 4:59pm
Therapies may affect ovarian function and cause early menopause, and many younger women can still pursue family planning with guidance from their care team.
October 29th 2025, 4:00pm
Exousia Pro, Inc. received orphan drug designation from the FDA for malignant glioma, also known as glioblastoma multiforme or GBM.
October 29th 2025, 3:00pm
CURE contributor Ronald D. Chin received a diagnosis of multiple myeloma in 2017 and has been in remission since 2023.
October 29th 2025, 1:00pm
The FDA has approved Blenrep with BVd as a third-line treatment for relapsed or refractory multiple myeloma.
October 28th 2025, 9:00pm
Dr. Sheldon M. Feldman says patients with breast cancer should accept support and make exercise and wellness priorities during treatment to improve outcomes.
FDA Fast Tracks JSKN003 in Ovarian Cancer
Keeping Her Hair Helped Her Feel Normal During Breast Cancer Treatment
With Cancer, 'Your Outlook Will be Significant in Beating this Disease'
Advancing Research Offers Hope for Patients With Liver Cancer